- Home
- CHSCO vs HCM Comparison
CHSCO vs HCM Comparison
Compare CHSCO & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHSCO
- HCM
- Stock Information
- Founded
- CHSCO N/A
- HCM 2000
- Country
- CHSCO United States
- HCM Hong Kong
- Employees
- CHSCO N/A
- HCM N/A
- Industry
- CHSCO Farming/Seeds/Milling
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- CHSCO Industrials
- HCM Health Care
- Exchange
- CHSCO Nasdaq
- HCM Nasdaq
- Market Cap
- CHSCO N/A
- HCM 2.4B
- IPO Year
- CHSCO N/A
- HCM N/A
- Fundamental
- Price
- CHSCO $27.08
- HCM $14.99
- Analyst Decision
- CHSCO
- HCM Hold
- Analyst Count
- CHSCO 0
- HCM 1
- Target Price
- CHSCO N/A
- HCM $19.00
- AVG Volume (30 Days)
- CHSCO N/A
- HCM 66.8K
- Earning Date
- CHSCO N/A
- HCM 02-26-2025
- Dividend Yield
- CHSCO N/A
- HCM N/A
- EPS Growth
- CHSCO N/A
- HCM N/A
- EPS
- CHSCO N/A
- HCM N/A
- Revenue
- CHSCO N/A
- HCM $610,806,000.00
- Revenue This Year
- CHSCO N/A
- HCM N/A
- Revenue Next Year
- CHSCO N/A
- HCM $21.06
- P/E Ratio
- CHSCO N/A
- HCM N/A
- Revenue Growth
- CHSCO N/A
- HCM N/A
- 52 Week Low
- CHSCO N/A
- HCM $11.93
- 52 Week High
- CHSCO N/A
- HCM $21.92
- Technical
- Relative Strength Index (RSI)
- CHSCO 61.24
- HCM 42.00
- Support Level
- CHSCO $25.90
- HCM $14.16
- Resistance Level
- CHSCO $27.15
- HCM $15.30
- Average True Range (ATR)
- CHSCO 0.36
- HCM 0.34
- MACD
- CHSCO 0.10
- HCM 0.10
- Stochastic Oscillator
- CHSCO 94.00
- HCM 60.37
About CHSCO CHS Inc. Class B Cumulative Redeemable Preferred Stock
CHS Inc is an integrated agricultural enterprise, that provides grain, food and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles to the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Maximum revenue is generated from Ag segment.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.